amikacin has been researched along with cinnamaldehyde in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Abd El Salam, ASG; Abd Elrazik, NA; Samaha, MM | 1 |
Li, X; Ma, S | 1 |
Ari Efiana, N; Bernkop-Schnürch, A; Dizdarević, A; Marić, M; Matuszczak, B; Shahzadi, I | 1 |
1 review(s) available for amikacin and cinnamaldehyde
Article | Year |
---|---|
Advances in the discovery of novel antimicrobials targeting the assembly of bacterial cell division protein FtsZ.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; Cell Division; Cytoskeletal Proteins | 2015 |
2 other study(ies) available for amikacin and cinnamaldehyde
Article | Year |
---|---|
Cytoprotective effects of cinnamaldehyde and adipoRon against cyclophosphamide-induced cardio-renal toxicity in rats: Insights into oxidative stress, inflammation, and apoptosis.
Topics: Animals; Antioxidants; Apoptosis; Cyclophosphamide; Drug-Related Side Effects and Adverse Reactions; Inflammation; Kidney; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Rats, Wistar | 2023 |
Imine bond formation as a tool for incorporation of amikacin in self-emulsifying drug delivery systems (SEDDS).
Topics: Acrolein; Administration, Oral; Amikacin; Benzaldehydes; Caco-2 Cells; Drug Carriers; Drug Liberation; Emulsions; Humans; Hydrophobic and Hydrophilic Interactions; Permeability; Serum Albumin, Bovine; Solubility; Toxicity Tests, Acute | 2021 |